1. Home
  2. BA vs VRTX Comparison

BA vs VRTX Comparison

Compare BA & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BA
  • VRTX
  • Stock Information
  • Founded
  • BA 1916
  • VRTX 1989
  • Country
  • BA United States
  • VRTX United States
  • Employees
  • BA N/A
  • VRTX N/A
  • Industry
  • BA Aerospace
  • VRTX EDP Services
  • Sector
  • BA Industrials
  • VRTX Technology
  • Exchange
  • BA Nasdaq
  • VRTX Nasdaq
  • Market Cap
  • BA 132.3B
  • VRTX 104.8B
  • IPO Year
  • BA N/A
  • VRTX 1991
  • Fundamental
  • Price
  • BA $176.50
  • VRTX $482.28
  • Analyst Decision
  • BA Buy
  • VRTX Buy
  • Analyst Count
  • BA 21
  • VRTX 27
  • Target Price
  • BA $200.68
  • VRTX $502.04
  • AVG Volume (30 Days)
  • BA 8.0M
  • VRTX 1.6M
  • Earning Date
  • BA 01-28-2025
  • VRTX 02-10-2025
  • Dividend Yield
  • BA N/A
  • VRTX N/A
  • EPS Growth
  • BA N/A
  • VRTX N/A
  • EPS
  • BA N/A
  • VRTX N/A
  • Revenue
  • BA $66,517,000,000.00
  • VRTX $10,625,800,000.00
  • Revenue This Year
  • BA $31.55
  • VRTX $12.55
  • Revenue Next Year
  • BA $15.70
  • VRTX $8.24
  • P/E Ratio
  • BA N/A
  • VRTX N/A
  • Revenue Growth
  • BA N/A
  • VRTX 10.06
  • 52 Week Low
  • BA $137.03
  • VRTX $377.85
  • 52 Week High
  • BA $213.77
  • VRTX $519.88
  • Technical
  • Relative Strength Index (RSI)
  • BA 55.22
  • VRTX 74.57
  • Support Level
  • BA $173.13
  • VRTX $430.81
  • Resistance Level
  • BA $181.78
  • VRTX $447.72
  • Average True Range (ATR)
  • BA 5.68
  • VRTX 11.82
  • MACD
  • BA -0.13
  • VRTX 6.92
  • Stochastic Oscillator
  • BA 45.54
  • VRTX 99.32

About BA Boeing Company (The)

Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed and Northrop to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: